Home/Filings/4/0001104659-25-121213
4//SEC Filing

BENDHEIM JACK 4

Accession 0001104659-25-121213

CIK 0001069899other

Filed

Dec 14, 7:00 PM ET

Accepted

Dec 15, 4:51 PM ET

Size

10.5 KB

Accession

0001104659-25-121213

Insider Transaction Report

Form 4
Period: 2025-12-11
BENDHEIM JACK
DirectorPresident and CEO10% Owner
Transactions
  • Sale

    Class A Common Stock

    2025-12-11$40.61/sh2,757$111,96142,195 total(indirect: See)
  • Sale

    Class A Common Stock

    2025-12-11$41.22/sh2,995$123,44439,200 total(indirect: See)
Holdings
  • Class A Common Stock

    16,840
BFI Co., LLC
10% Owner
Transactions
  • Sale

    Class A Common Stock

    2025-12-11$40.61/sh2,757$111,96142,195 total(indirect: See)
  • Sale

    Class A Common Stock

    2025-12-11$41.22/sh2,995$123,44439,200 total(indirect: See)
Holdings
  • Class A Common Stock

    16,840
Footnotes (5)
  • [F1]The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by BFI Co., LLC ("BFI") on May 30, 2025.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.035 to $41.025. The Reporting Person undertakes to provide to Phibro Animal Health Corporation (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote and in footnote 4.
  • [F3]The reported securities are directly held by BFI. Jack Bendheim, a reporting person, director and officer of the Issuer, exercises voting and dispositive power over BFI and may be deemed to have shared voting and investment power over the securities held by BFI. Mr. Bendheim disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.095 to $41.38.
  • [F5]The reported securities are directly held by Jack Bendheim.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeother

Related Parties

1
  • filerCIK 0001241560

Filing Metadata

Form type
4
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:51 PM ET
Size
10.5 KB